2025-05-27 – Press Releases – www.prnewswire.com
YANTAI, China, May 27, 2025 /PRNewswire/ — On May 27, RemeGen Co., Ltd.(688331.SH / 09995.HK) announced that Telitacicept has officially been approved for marketing in China by the National Medical Products Administration (NMPA) for the treatment of adult patients with anti-acetylcholine…
